Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen IncfiledCriticalAmgen Inc
Publication of MY155313ApublicationCriticalpatent/MY155313A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
THE PRESENT INVENTION PROVIDES VARIANT ACTIVIN IIB SOLUBLE RECEPTOR POLYPEPTIDES AND PROTEINS CAPABLE OF BINDING AND INHIBITING THE ACTIVITIES OF ACTIVIN A, MYOSTATIN, OR GDF-11. THE PRESENT INVENTION ALSO PROVIDES POLYNUCLEOTIDES, VECTORS AND HOST CELLS CAPABLE OF PRODUCING THE VARIANT POLYPEPTIDES AND PROTEINS. COMPOSITIONS AND METHODS FOR TREATING MUSCLE-WASTING AND OTHER DISEASES AND DISORDERS ARE ALSO PROVIDED.
MYPI20093636A2007-03-062008-03-06Variant activin receptor polypeptides and uses thereof
MY155313A
(en)